China's A-share market showed divergent early trade. At midday the Shanghai Composite was up 0.76%, the Shenzhen Composite rose 0.61% and the ChiNext fell 0.65%. Innovative drug names led gains: Changshan Pharmaceutical +20%, with Zhongsheng Pharmaceutical, Joinn New Drug and Shuanglu Pharmaceutical hitting limit-up. AI application stocks were active; Fushi Holdings and Zhewen Interactive hit limit-up. Outperformers included film chains, baijiu, precious metals, property services and gaming; lag

China's A-share market showed divergent early trade. At midday the Shanghai Composite was up 0.76%, the Shenzhen Composite rose 0.61% and the ChiNext fell 0.65%. Innovative drug names led gains: Changshan Pharmaceutical +20%, with Zhongsheng Pharmaceutical, Joinn New Drug and Shuanglu Pharmaceutical hitting limit-up. AI application stocks were active; Fushi Holdings and Zhewen Interactive hit limit-up. Outperformers included film chains, baijiu, precious metals, property services and gaming; laggards included semiconductors, energy metals, brokerages, industrial gases, silicon carbide and lab-grown diamond concepts. More than 4,400 stocks advanced and half-day turnover exceeded CNY 2.18 trillion.